Southeast Netherlands Advanced Metastatic Breast Cancer Registry

Recruiting now

Conditions studied: Advanced Breast Cancer, Metastatic Breast Cancer

In brief

The Southeast Netherlands Advanced Breast Cancer (SONABRE) Registry is a real life multi-center study. The registry aims to include all patients diagnosed with advanced breast cancer as of 2007 in 11 hospitals in the Netherlands. Data on patient, tumor and treatment characteristics are collected retrospectively from electronic medical files by trained registry clerks.

Key facts

Study ID

NCT03577197

Run by

Academisch Ziekenhuis Maastricht

People needed

7000

Starts

2007-01-01

Expected to finish

2027-12-31

Last updated by the study team

2024-07-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosed with de novo or recurrent advanced breast cancer since 2007
• Diagnosed with or treated for advanced breast cancer in one of the participating hospitals
• Participating hospitals (period of inclusion): Maastricht UMC+ (2007-2025), Zuyderland hospitals Sittard/Heerlen (2007-2025), Amphia Hospital Breda (2013-2025), Catharina Hospital Eindhoven (2007-2025), Elkerliek Hospital Helmond (2010-2025), Maxima Medical Center Veldhoven/Eindhoven (2007-2025), Jeroen Bosch Hospital Den Bosch (2013-2025), Laurentius Hospital Roermond (2007-2025), St. Annaziekenhuis Geldrop (2007-2025), St. Elisabeth Hospital Tilburg (2007-2009), St. Jans Gasthuis Weert (2007-2025), VieCuri Medical Center Venlo/Venray (2013-2025), all in the Netherlands.
• Hospitals (and periods) were eligible for inclusion if (distant) registration from Maastricht UMC+ was possible.
• The inclusion period may be prolonged after 2025.
• Exclusion Criteria: none

Where it is running

• Multiple hospitals in the Netherlands (see Eligibility) — Maastricht, Netherlands (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.